Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121931572 | 12193157 | 2 | F | 20160720 | 20160319 | 20160728 | EXP | JP-AMGEN-JPNSP2016035003 | AMGEN | SAKAI R, SAKURAI S, OKADA T, ET AL. CASE REPORT; ATYPICAL POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES) AND THROMBOTIC MICROANGIOPATHY (TMA) IN A HEMODIALYSIS PATIENT WITH ANCA - ASSOCIATED VASCULITIS: A CASE REPORT.. THE JOURNAL OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE. 2016;105:275-280 | 59.00 | YR | A | F | Y | 45.00000 | KG | 20160728 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121931572 | 12193157 | 1 | PS | NESP | DARBEPOETIN ALFA | 1 | Unknown | 60 MUG, QWK | U | 103951 | 60 | UG | INJECTION | /wk | |||||
| 121931572 | 12193157 | 2 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | 20 MG, UNK | 0 | 20 | MG | ||||||||
| 121931572 | 12193157 | 3 | SS | CILNIDIPINE | CILNIDIPINE | 1 | Oral | 2.5 MG, UNK | 0 | 2.5 | MG | TABLET | |||||||
| 121931572 | 12193157 | 4 | SS | VALSARTAN. | VALSARTAN | 1 | Oral | 40 MG, UNK | 0 | 40 | MG | TABLET | |||||||
| 121931572 | 12193157 | 5 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | 40 MG, UNK | 0 | 40 | MG | ||||||||
| 121931572 | 12193157 | 6 | SS | SULFAMETHOXAZOLE AND TRIMETHOPRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Unknown | 480 MG, 3 TIMES/WK | 0 | 480 | MG | TIW | |||||||
| 121931572 | 12193157 | 7 | SS | ESOMEPRAZOLE MAGNESIUM. | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 20 MG, UNK | 0 | 20 | MG | ||||||||
| 121931572 | 12193157 | 8 | SS | ALFACALCIDOL | ALFACALCIDOL | 1 | Oral | 0.25 MUG, UNK | 0 | .25 | UG | ||||||||
| 121931572 | 12193157 | 9 | SS | REBAMIPIDE | REBAMIPIDE | 1 | Oral | 300 MG, UNK | 0 | 300 | MG | ||||||||
| 121931572 | 12193157 | 10 | SS | DILAZEP HYDROCHLORIDE | DILAZEP DIHYDROCHLORIDE | 1 | Oral | 300 MG, UNK | 0 | 300 | MG | ||||||||
| 121931572 | 12193157 | 11 | SS | ALENDRONATE SODIUM HYDRATE | ALENDRONATE SODIUM | 1 | Unknown | 35 MG, QWK | 0 | 35 | MG | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121931572 | 12193157 | 1 | Product used for unknown indication |
| 121931572 | 12193157 | 2 | Product used for unknown indication |
| 121931572 | 12193157 | 3 | Product used for unknown indication |
| 121931572 | 12193157 | 4 | Product used for unknown indication |
| 121931572 | 12193157 | 5 | Product used for unknown indication |
| 121931572 | 12193157 | 6 | Product used for unknown indication |
| 121931572 | 12193157 | 7 | Product used for unknown indication |
| 121931572 | 12193157 | 8 | Product used for unknown indication |
| 121931572 | 12193157 | 9 | Product used for unknown indication |
| 121931572 | 12193157 | 10 | Product used for unknown indication |
| 121931572 | 12193157 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121931572 | 12193157 | OT |
| 121931572 | 12193157 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121931572 | 12193157 | Blood pressure increased | |
| 121931572 | 12193157 | Chronic gastritis | |
| 121931572 | 12193157 | Duodenal polyp | |
| 121931572 | 12193157 | Gastric polyps | |
| 121931572 | 12193157 | Gastrooesophageal reflux disease | |
| 121931572 | 12193157 | Hiatus hernia | |
| 121931572 | 12193157 | Posterior reversible encephalopathy syndrome | |
| 121931572 | 12193157 | Retinal haemorrhage | |
| 121931572 | 12193157 | Thrombotic microangiopathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |